Clinical Trial Update: Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating the fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and dolutegravir as second-line antiretroviral ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• tenofovir disoproxil fumarate/lamivudine/dolutegravir (tenofovir disoproxil fumarate; lamivudine; dolutegravir)

Snippet

Sponsor: University of Cape Town | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2024-08-09